Novimid

Weight-management programs, reviewed by licensed providers.

Compare Semaglutide and Tirzepatide below. Completing intake does not guarantee a prescription.

Semaglutide Program

May be compounded — not FDA-approved

A clinician-guided weight-management program using semaglutide, discussed only after clinical eligibility review. Treatment is never guaranteed by intake alone.

Semaglutide

Clinician-guided program · if prescribed

Program includes:
Clinical eligibility review first
Secure medical intake after checkout
Provider oversight if treatment continues
Discreet fulfillment when prescribed
Routine follow-up required by the program
Important

Completing intake does not guarantee a prescription. Refund terms apply if treatment is not prescribed, as disclosed at checkout.

Product imagery is illustrative; labels, lots, and concentrations shown are not real.

Program price disclosed at checkout · if prescribed

Start clinical intake

Start with a clinical review — not a template.

The Semaglutide Program may be discussed only after clinical intake and licensed-provider review. Completing intake does not guarantee eligibility or a prescription. If appropriate, care is individualized and fulfilled through a licensed pharmacy partner.

Secure medical intake

After checkout, you complete a secure health intake and identity-verification steps so a licensed clinician can review your information.

Licensed-provider review

An independent U.S.-licensed clinician evaluates whether treatment is clinically appropriate. Purchasing a program does not guarantee a prescription.

Pharmacy fulfillment if prescribed

If prescribed, medication is dispensed by a licensed pharmacy partner. Compounded medications, when used, are not FDA-approved finished products.

Start clinical intake

Care starts with
clinical review.

Weight Management · Semaglutide Program

Weight-management care, reviewed by licensed providers.

A clinician-guided weight-management program using semaglutide, discussed only after clinical eligibility review. Treatment is never guaranteed by intake alone.

If prescribed, dosing and follow-up are directed by your licensed clinician. Compounded medications, when used, are not FDA-approved finished products.

Completing intake does not guarantee a prescription.

  • Clinical eligibility review first
  • Secure medical intake after checkout
  • Provider oversight if treatment continues
  • Discreet fulfillment when prescribed

Program price disclosed at checkout · if prescribed

Start clinical intake

Completing intake does not guarantee a prescription. Product imagery is illustrative.

How the Semaglutide Program typically proceeds

Process steps after checkout — not outcome promises. Individual experiences vary. Completing intake does not guarantee a prescription.

Adult reviewing intake materials at home

After checkout · Complete intake

You finish the secure medical intake and identity-verification steps required for licensed-provider review. This reserves clinical review — it is not a purchase of a prescription.

Adult reviewing a care plan after provider evaluation

Licensed-provider review

A U.S.-licensed clinician reviews your information and may request follow-up details, labs, or a live consultation. Treatment is provided only if clinically appropriate.

Adult at home during ongoing program support

If prescribed · Ongoing oversight

When prescribed, medication is fulfilled through a licensed pharmacy partner. Routine follow-up required by the program continues with your care team. Results are not guaranteed.

Frequently asked questions

Illustrative Semaglutide program product photo
  • Novimid is a technology platform that connects eligible patients with independent U.S.-licensed clinicians for weight-management programs. Novimid is not a pharmacy. Fulfillment occurs through licensed pharmacy partners only when prescribed.

Start clinical intake

Compounded medications are not FDA-approved drug products. They are prepared for individual patients pursuant to a valid prescription through licensed U.S. pharmacy partners when clinically indicated. Compounding disclosure